Amizon
Based on 1 Customer Validation
Amizon is an orally effective antiviral and anti-inflammatory agent. Amizon inhibits influenza virus replication and restricts viral RNA synthesis. Amizon reduces the mRNA expression of COX-1, COX-2, NF-κB, TGF1β, IL-1 and IL-6, and stimulates the secretion and mRNA expression of IL-10. Amizon inhibits the oxidative activity of macrophages and possesses antioxidant and free radical-scavenging activities. Amizon is applicable to research related to influenza and acute respiratory viral infections.
For research use only. We do not sell to patients.
- Purity : 99.92%
- CAS No.: 201349-37-3
- Formula: C14H15IN2O
- Molecular Weight:354.19
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
In Vitro
Enisamium (40-1000 μM; 24 h) dose-dependently reduces replication of multiple influenza A (including oseltamivir-resistant influenza AH275Y mutant) and B viruses in differentiated NHBE cells, with the greatest reduction of 2.8 log10TCID50/mL observed at 1000 μM for 24 hours against influenza A/TN/1-560/09 [H1N1][1].
Enisamium (500-1000 μM; 24-48 h) significantly reduces replication of influenza A/Brisbane/59/2007 (H1N1) virus in differentiated NHBE cells at MOIs of 0.01, 0.001, and 0.0001 PFU/cell when administered post-infection[1].
Enisamium (10-1000 μM; 24 h) exhibits low permeability (1.1-1.6%) across differentiated NHBE cells after 24 hours of exposure at 10-1000 μM, with intracellular concentrations increasing in a dose-dependent manner[1].
Enisamium (2000 μM; total 24 h) significantly reduces replication and matrix gene expression of influenza A/Brisbane/59/2007 (H1N1) virus in differentiated NHBE cells when added between 1 hour before and 10 hours after viral inoculation for a total 24-hour incubation[1].
Enisamium (100-1000 μM; 24 h pre-incubation, maintained throughout) significantly reduces replication of influenza A/Brisbane/59/2007 (H1N1) virus in differentiated NHBE cells over 24 and 48 hours post-inoculation[1].
Enisamium iodide (10-100 μM; 48 h) inhibits mRNA expression of pro-inflammatory mediators (COX-1, COX-2, NF-κB, TGF1β, IL-1, IL-6) and increases anti-inflammatory IL-10 mRNA expression in phytohemagglutinin-stimulated human PBMC, with 10 μM reducing target pro-inflammatory gene expression by up to 67% and increasing IL-10 expression by 73%[2].
Enisamium iodide (50 μM; 72 h) stimulates secretion of the anti-inflammatory cytokine IL-10 by 1.5-fold with statistical significance in phytohemagglutinin-stimulated human PBMC[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 201349-37-3
-
Appearance Solid
-
Molecular Weight 354.19
-
Formula C14H15IN2O
-
Color Light yellow to yellow
-
SMILES
C[N+]1=CC=C(C(NCC2=CC=CC=C2)=O)C=C1.[I-]
-
Synonyms
Enisamium iodide
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (282.33 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.8233 mL | 14.1167 mL | 28.2334 mL | 70.5836 mL |
| 5 mM | 0.5647 mL | 2.8233 mL | 5.6467 mL | 14.1167 mL | |
| 10 mM | 0.2823 mL | 1.4117 mL | 2.8233 mL | 7.0584 mL | |
| 15 mM | 0.1882 mL | 0.9411 mL | 1.8822 mL | 4.7056 mL | |
| 20 mM | 0.1412 mL | 0.7058 mL | 1.4117 mL | 3.5292 mL | |
| 25 mM | 0.1129 mL | 0.5647 mL | 1.1293 mL | 2.8233 mL | |
| 30 mM | 0.0941 mL | 0.4706 mL | 0.9411 mL | 2.3528 mL | |
| 40 mM | 0.0706 mL | 0.3529 mL | 0.7058 mL | 1.7646 mL | |
| 50 mM | 0.0565 mL | 0.2823 mL | 0.5647 mL | 1.4117 mL | |
| 60 mM | 0.0471 mL | 0.2353 mL | 0.4706 mL | 1.1764 mL | |
| 80 mM | 0.0353 mL | 0.1765 mL | 0.3529 mL | 0.8823 mL | |
| 100 mM | 0.0282 mL | 0.1412 mL | 0.2823 mL | 0.7058 mL |